Alivernini, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 2.609
EU - Europa 2.220
AS - Asia 621
AF - Africa 20
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 5.487
Nazione #
US - Stati Uniti d'America 2.595
IT - Italia 481
SE - Svezia 411
PL - Polonia 375
CN - Cina 324
DE - Germania 257
FR - Francia 199
IE - Irlanda 159
SG - Singapore 118
UA - Ucraina 93
GB - Regno Unito 70
IN - India 67
FI - Finlandia 43
RU - Federazione Russa 42
TR - Turchia 30
BE - Belgio 21
HK - Hong Kong 21
JP - Giappone 16
CI - Costa d'Avorio 13
IR - Iran 13
VN - Vietnam 12
CA - Canada 11
CH - Svizzera 9
ES - Italia 8
NL - Olanda 8
RO - Romania 6
CZ - Repubblica Ceca 5
GR - Grecia 5
IL - Israele 5
MD - Moldavia 5
ZA - Sudafrica 5
CL - Cile 4
AR - Argentina 3
DK - Danimarca 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MX - Messico 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
AU - Australia 2
BR - Brasile 2
EE - Estonia 2
EU - Europa 2
KR - Corea 2
MY - Malesia 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
EC - Ecuador 1
ID - Indonesia 1
IQ - Iraq 1
LU - Lussemburgo 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
Totale 5.487
Città #
Chandler 508
Warsaw 365
Ashburn 242
Fairfield 168
Dublin 142
Rome 120
Wilmington 115
Dearborn 104
New York 101
Woodbridge 98
Ann Arbor 96
Seattle 89
Houston 75
Nanjing 72
Cambridge 68
Singapore 68
Milan 66
Cattolica 60
Jacksonville 54
San Mateo 53
Princeton 50
Boston 47
Beijing 45
Bremen 44
Chicago 37
Marseille 35
Moscow 29
Redwood City 28
Izmir 24
Pune 23
Redmond 22
Hong Kong 20
Boardman 19
Lawrence 19
Nanchang 19
Brussels 16
Kunming 16
London 16
Helsinki 15
Norwalk 15
Hangzhou 14
Shenyang 14
Tianjin 14
Abidjan 13
Lancaster 12
Andover 11
Dong Ket 10
Hebei 10
Mountain View 10
Munich 10
Santa Maria 10
Washington 10
Busto Arsizio 9
Guangzhou 9
Los Angeles 9
San Diego 9
Tokyo 9
Fuzhou 8
Augusta 7
Jiaxing 7
Jinan 7
Leawood 7
Nürnberg 7
Strasbourg 7
Zurich 7
Dijon 6
Falls Church 6
Lappeenranta 6
Parma 6
Phoenix 6
San Vito Chietino 6
Brno 5
Catania 5
Herenthout 5
Kraków 5
Shanghai 5
Toronto 5
University Park 5
Vancouver 5
Amsterdam 4
Boydton 4
Edinburgh 4
Fremont 4
Muizenberg 4
Naples 4
Renton 4
Senigallia 4
Tiraspol 4
Wuhan 4
Zhengzhou 4
Ashfield 3
Changchun 3
Changsha 3
Chengdu 3
Chieti 3
Delhi 3
Desio 3
Genoa 3
Kish 3
Lisbon 3
Totale 3.593
Nome #
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 297
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 267
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 256
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 206
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 186
Synovial tissue macrophages: friend or foe? 151
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 133
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 132
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 132
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 121
Has shoulder ultrasonography got a predictive value in Polymialgia Rheumatica. In: EULAR. 111
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 96
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 92
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 88
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 88
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 82
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 81
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 81
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 80
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 79
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 79
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 76
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 74
Postural control and disability in patients with early rheumatoid arthritis 74
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 73
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 72
Sarilumab use in severe SARS-CoV-2 pneumonia 68
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 67
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 65
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 64
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 64
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 62
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 62
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 62
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 62
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 62
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 61
Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission 59
The pathogenesis of rheumatoid arthritis 58
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 58
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 58
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 57
Biomarkers of joint damage in rheumatoid arthritis: where are we in 2013? 53
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 52
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 51
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 51
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 50
The B side of rheumatoid arthritis pathogenesis 50
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 50
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology 50
Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? 49
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 49
Ultrasound assessment as predictor of disease relapse in children and adults with arthritis in clinical stable remission: new findings but still unmet needs 48
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 45
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study 44
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 43
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 41
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity 39
Telemedicine will not keep us apart in COVID-19 pandemic 39
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 38
RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection 37
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 36
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 36
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 35
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 33
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 32
Malnutrition in COVID-19 survivors: prevalence and risk factors 30
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 28
Inflammation causes remodeling of mitochondrial cytochrome c oxidase mediated by the bifunctional gene C15orf48 27
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 27
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 26
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis 24
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 23
The Role of Neutrophils in Spondyloarthritis: A Journey across the Spectrum of Disease Manifestations 21
Driving chronicity in rheumatoid arthritis: Perpetuating role of myeloid cells 17
COVID-19 atypical Parsonage-Turner syndrome: a case report 16
Malnutrition in COVID-19 survivors: prevalence and risk factors 16
Evaluating antirheumatic treatments using synovial biopsy: A recommendation for standardisation to be used in clinical trials 15
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 11
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution 11
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 11
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 11
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 10
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 9
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 9
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 9
Using explainable artificial intelligence to predict and forestall flare in rheumatoid arthritis 8
A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: A starter study post-hoc analysis 6
Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing 4
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 3
Totale 5.619
Categoria #
all - tutte 25.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.021 109 91 85 179 73 131 75 51 63 45 80 39
2020/2021568 59 43 26 34 75 38 49 11 73 63 72 25
2021/2022719 95 46 32 52 45 18 15 74 44 51 97 150
2022/20231.525 177 184 114 231 115 187 65 121 191 62 51 27
2023/20241.056 42 219 50 52 43 189 96 37 39 70 141 78
2024/202522 22 0 0 0 0 0 0 0 0 0 0 0
Totale 5.619